FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 10/02/2019 |
3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Ordinary Shares(1) | 17,195 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Options (right to buy) | (2) | 12/09/2023 | Ordinary Shares(1) | 25,005 | $40.15 | D | |
Stock Options (right to buy) | (3) | 03/11/2024 | Ordinary Shares(1) | 15,002 | $48.76 | D | |
Stock Options (right to buy) | (4) | 02/11/2025 | Ordinary Shares(1) | 54,623 | $57.35 | D | |
Stock Options (right to buy) | (5) | 02/11/2026 | Ordinary Shares(1) | 54,950 | $55.75 | D | |
Stock Options (right to buy) | (6) | 02/14/2027 | Ordinary Shares(1) | 62,364 | $34.9 | D | |
Stock Options (right to buy) | (7) | 09/18/2027 | Ordinary Shares(1) | 33,339 | $16.99 | D | |
Stock Options (right to buy) | (8) | 02/08/2028 | Ordinary Shares(1) | 50,231 | $18.61 | D | |
Restricted Share Units | (9) | (9) | Ordinary Shares(1) | 7,852 | (10) | D | |
Restricted Share Units | (11) | (11) | Ordinary Shares(1) | 19,702 | (10) | D | |
Restricted Share Units | (12) | (12) | Ordinary Shares(1) | 35,820 | (10) | D |
Explanation of Responses: |
1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
2. Stock options were granted on December 9, 2013, with 8,335 having vested on each of December 9, 2015, December 9, 2016 and December 9, 2017. |
3. Stock options were granted on March 12, 2014, with 5,000 having vested on each of March 12, 2015 and March 12, 2016 and 5,002 having vested on March 12, 2017. |
4. Stock options were granted on February 12, 2015, with 18,207 having vested on each of February 12, 2017 and February 12, 2018 and 18,209 on February 12, 2019. |
5. Stock options were granted on February 12, 2016, with 18,316 having vested on each of February 12, 2018 and February 12, 2019 and 18,318 vesting on February 12, 2020. |
6. Stock options were granted on February 14, 2017, with 20,788 having vested on February 14, 2019, and 20,788 vesting on each of February 14, 2020 and February 14, 2021. |
7. Stock options were granted on September 18, 2017 and vested on September 18, 2019. |
8. Stock options were granted on February 9, 2018, with 16,743 vesting on each of February 9, 2020 and February 9, 2021 and 16,745 vesting on February 9, 2022. |
9. Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021. |
10. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
11. Restricted share units were granted on February 9, 2018, with 6,567 vesting on each of February 9, 2020 and February 9, 2021 and 6,568 vesting on February 9, 2022. |
12. Restricted share units were granted on March 4, 2019, with 11,940 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023. |
Remarks: |
/s/ Dov Bergwerk, as attorney-in-fact for Eric Drape | 10/15/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |